Safety and efficacy of the FAKHRAVAC compared with BBIBP-Corv2 against SARS-CoV-2 in adults: a non-inferiority multi-center trial

We compared Fakhravac and BBIBP-Corv2 vaccines in a phase III trial. We conducted a multicenter, parallel-group, active-control, non-inferiority clinical trial with pragmatic considerations assessing the safety and efficacy of Fakhravac and BBIBP-Corv2 vaccines. We started with two randomized double...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Virology Journal 2023, Vol.20 (1)
Hauptverfasser: Solaymani-Dodaran, Masoud, Basiri, Pouria, Moradi, Milad, Gohari, Kimiya, Sheidaei, Ali, Ahi, Mohammadreza, Ghafoori Naeeni, Farzad, Ansarifar, Akram, Rahimi, Zahra, Gholami, Fatemeh, Karimi Rahjerdi, Ahmad, Hamidi Farahani, Ramin, Naderi saffar, Kosar, Ghasemi, Soheil, Shooshtari, Ali, Honari, Mohsen, Mozafari, Ali, Khodaverdloo, Samane, Forooghizadeh, Mohsen
Format: Report
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!